Your browser doesn't support javascript.
loading
Exome sequencing in patients with microphthalmia, anophthalmia, and coloboma (MAC) from a consanguineous population.
Islam, Farrah; Htun, Stephanie; Lai, Li-Wen; Krall, Max; Poranki, Menitha; Martin, Pierre-Marie; Sobreira, Nara; Wohler, Elizabeth S; Yu, Jingwei; Moore, Anthony T; Slavotinek, Anne M.
Afiliação
  • Islam F; Department of Ophthalmology, Al-Shifa Eye Trust Hospital, Rawalpindi, Pakistan.
  • Htun S; Division of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Lai LW; Department of Pathology, University of Arizona, Tucson, Arizona, USA.
  • Krall M; Division of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Poranki M; Division of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Martin PM; Institute of Human Genetics, University of California San Francisco, San Francisco, California, USA.
  • Sobreira N; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wohler ES; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Yu J; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Moore AT; Dept. Ophthalmology, University of California San Francisco, San Francisco, California, USA.
  • Slavotinek AM; Division of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
Clin Genet ; 98(5): 499-506, 2020 11.
Article em En | MEDLINE | ID: mdl-32799327
ABSTRACT
Next-generation sequencing strategies have resulted in mutation detection rates of 21% to 61% in small cohorts of patients with microphthalmia, anophthalmia and coloboma (MAC), but despite progress in identifying novel causative genes, many patients remain without a genetic diagnosis. We studied a cohort of 19 patients with MAC who were ascertained from a population with high rates of consanguinity. Using single nucleotide polymorphism (SNP) arrays and whole exome sequencing (WES), we identified one pathogenic variant in TENM3 in a patient with cataracts in addition to MAC. We also detected novel variants of unknown significance in genes that have previously been associated with MAC, including KIF26B, MICU1 and CDON, and identified variants in candidate genes for MAC from the Wnt signaling pathway, comprising LRP6, WNT2B and IQGAP1, but our findings do not prove causality. Plausible variants were not found for many of the cases, indicating that our current understanding of the pathogenesis of MAC, a highly heterogeneous group of ocular defects, remains incomplete.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular / Anoftalmia / Coloboma / Microftalmia / Proteínas Supressoras de Tumor / Proteínas de Membrana / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Paquistão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular / Anoftalmia / Coloboma / Microftalmia / Proteínas Supressoras de Tumor / Proteínas de Membrana / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Paquistão